tirzepatide naion risk Semaglutide linked to increased of vision loss in diabetes patients Does Zepbound Cause NAION? Vision

GLP-1s as additive value, not SGLT2i competition KDIGOs 2024 CKD guideline reinforced a shift toward multi-mechanism CKD management, positioning GLP-1s as additive, rather than competitive, with Sodium-Glucose Cotransporter-2 inhibitors (SGLT2i)

Treatment with liraglutide was initiated with a dose of 0.6 mg/day and being gradually increased to 2.4 mg/day during the following 8 weeks

Although both myricitrin and myricetin induced MN formation in human TK6 lymphoblastoid cells following a 24 h exposure without metabolic activation, neither compound induced MN following exposure for 4 h in the presence of metabolic activation

Please do not adjust your dosage without approval from your doctor. What are the side effects of tirzepatide

Daniela Avino, MD, neonatologist, Neonatal Intensive Care Unit, Hpital Universitaire des Enfants Reine Fabiola, Hpital Universitaire de Bruxelles, Universit libre de Bruxelles, Brussels, Belgium